BioLight Life Sciences Ltd. (TLV:BOLT)
Israel · Delayed Price · Currency is ILS · Price in ILA 234.30
+16.40 (7.53%)
Apr 3, 2026, 1:44 PM IDT
BioLight Life Sciences Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
21.20M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 219.00K | 101.00K | 85.59% |
| Dec 31, 2023 | 118.00K | 55.00K | 87.30% |
| Dec 31, 2022 | 63.00K | 60.00K | 2,000.00% |
| Dec 31, 2021 | 3.00K | -28.00K | -90.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Evogene | 12.28M |
| Clal Biotechnology Industries | 11.55M |
| BioLineRx | 3.76M |
| XTL Biopharmaceuticals | 3.26M |
| Can-Fite BioPharma | 1.29M |
| Geffen Residence & Renewal | 78.00K |